UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma

Scientific reports, 2022-01, Vol.12 (1), p.1279-1279, Article 1279

2022

Volltextzugriff (PDF)

Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma

Investigational new drugs, 2020-10, Vol.38 (5), p.1559-1569

2020

Volltextzugriff (PDF)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma

Frontiers in cell and developmental biology, 2021-06, Vol.9, p.616271-616271

2021

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

BMC cancer, 2022-01, Vol.22 (1), p.56-56, Article 56

2022

Volltextzugriff (PDF)

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study

Cancer Immunology, Immunotherapy, 2020-03, Vol.69 (3), p.399-405

2020

Volltextzugriff (PDF)

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

BMC cancer, 2020-07, Vol.20 (1), p.698-6, Article 698

2020

Volltextzugriff (PDF)

Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study

Investigational new drugs, 2021-12, Vol.39 (6), p.1724-1731

2021

Volltextzugriff (PDF)

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Zhongguo fei ai za zhi, 2022-09, Vol.25 (9), p.651-657

2022

Volltextzugriff (PDF)

High cumulative doxorubicin dose for advanced soft tissue sarcoma

BMC cancer, 2020-11, Vol.20 (1), p.1139, Article 1139

2020

Volltextzugriff (PDF)

The efficacy and clinical survival outcome of different first-line treatments in EGFR-mutant non-small cell lung cancer with brain metastases

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2028-2028

2021

Volltextzugriff (PDF)

Comparison of population characteristics, treatment modes, and clinical outcomes of patients with advanced non-small cell lung cancer in clinical trials and in the real world received PD-1/PD-L1 inhibitor

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18733-e18733

2021

Volltextzugriff (PDF)

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation

Lung cancer (Amsterdam, Netherlands), 2019-02, Vol.128, p.6-12

2019

Volltextzugriff (PDF)

Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study

Journal of cancer research and clinical oncology, 2019-01, Vol.145 (1), p.235-240

2019

Volltextzugriff (PDF)

Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor

Annals of palliative medicine, 2021-03, Vol.10 (3), p.3039-3049

2021

Volltextzugriff (PDF)

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer

Cancer management and research, 2021-01, Vol.13, p.2279-2286

2021

Volltextzugriff (PDF)

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Zhongguo fei ai za zhi, 2022-09, Vol.25 (9), p.651-657

2022

Volltextzugriff (PDF)

Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study

Cancer management and research, 2020-02, Vol.12, p.1339-1346

2020

Volltextzugriff (PDF)

Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study

Zhōnghuá zhŏngliú zázhì, 2020-11, Vol.42 (11), p.961

2020

Volltextzugriff (PDF)

Perception Layer Lightweight Certificateless Authentication Scheme for IoT-Based Emergency Logistics

IEEE access, 2023-01, Vol.11, p.1-1

2023

Volltextzugriff (PDF)

Amperometric hydrogen gas sensor based on Pt/C/Nafion electrode and ionic electrolyte

Sensors and actuators. B, Chemical, 2022-09, Vol.367, p.132137, Article 132137

2022

Volltextzugriff (PDF)

Multi-View Block Matrix-Based Graph Convolutional Network

Engineering letters, 2024-06, Vol.32 (6), p.1073

2024

Volltextzugriff (PDF)

Pillararene-functionalized rhodium nanoparticles for efficient catalytic reduction and photothermal sterilization

Chemical communications (Cambridge, England), 2022-11, Vol.58 (94), p.1379-1382

2022

Volltextzugriff (PDF)

Adaptive Neighbor Graph Aggregated Graph Attention Network for Heterogeneous Graph Embedding

ACM transactions on knowledge discovery from data, 2024-01, Vol.18 (1), p.1-21, Article 29

2024

Volltextzugriff (PDF)

MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb

Oncology letters, 2017-05, Vol.13 (5), p.3866-3872

2017

Volltextzugriff (PDF)

E-cadherin-mediated contact of endothelial progenitor cells with mesenchymal stem cells through β-catenin signaling

Cell biology international, 2016-04, Vol.40 (4), p.407-418

2016

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(27)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(14)
Oncology
(11)
Humans
(9)
Chemotherapy
(8)
Female
(7)
Male
(7)
Patients
(7)
Sarcoma
(7)
Cancer Therapies
(6)
Middle Aged
(5)
Retrospective Studies
(5)
Adult
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Clinical Trials
(4)
Disease Control
(4)
Doxorubicin
(4)
Immunotherapy
(4)
Lung Neoplasms - Drug Therapy
(4)
Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma

Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

High cumulative doxorubicin dose for advanced soft tissue sarcoma

The efficacy and clinical survival outcome of different first-line treatments in EGFR-mutant non-small cell lung cancer with brain metastases

Comparison of population characteristics, treatment modes, and clinical outcomes of patients with advanced non-small cell lung cancer in clinical trials and in the real world received PD-1/PD-L1 inhibitor

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation

Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study

Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study

Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study

Perception Layer Lightweight Certificateless Authentication Scheme for IoT-Based Emergency Logistics

Amperometric hydrogen gas sensor based on Pt/C/Nafion electrode and ionic electrolyte

Multi-View Block Matrix-Based Graph Convolutional Network

Pillararene-functionalized rhodium nanoparticles for efficient catalytic reduction and photothermal sterilization

Adaptive Neighbor Graph Aggregated Graph Attention Network for Heterogeneous Graph Embedding

MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb

E-cadherin-mediated contact of endothelial progenitor cells with mesenchymal stem cells through β-catenin signaling

Suchergebnisse filtern